For Research Purposes Only — Not intended for human consumption or therapeutic use

Retatrutide simultaneously activates GIP, GLP-1, and glucagon receptors — the most advanced tri-agonist peptide available. Designed for women whose bodies have stopped responding to conventional approaches.
3×
Receptor Targets
GIP · GLP-1 · Glucagon
99.1%
HPLC Purity
3rd Party Verified
$129
Per 10mg Vial
Free shipping over $200
Formulated for women's hormonal biology · ISO/IEC 17025 certified · Discreet insulated shipping
Most weight loss peptides target a single receptor. Retatrutide is the only tri-agonist that fires all three metabolic pathways at once — delivering results that single-action compounds simply cannot match.
GIP Receptor
GIP (Glucose-dependent Insulinotropic Polypeptide) activation dramatically improves insulin sensitivity — the root cause of weight gain in most women over 35. It also directly triggers fat cell lipolysis, releasing stored fat for energy.
GLP-1 Receptor
GLP-1 (Glucagon-Like Peptide-1) activation sends powerful fullness signals to the brain's hunger centers, slows gastric emptying for prolonged satisfaction, and eliminates the hormonal cravings that derail diets.
Glucagon Receptor
Glucagon receptor agonism is the third lever unique to Retatrutide. It directly activates fat oxidation — the process of burning stored fat for energy — and increases resting metabolic rate even between meals.

After 35, declining estrogen, shifting progesterone, and increasing cortisol fundamentally change how your body stores and burns fat. The result: the calorie-cutting and exercise routines that worked in your 20s stop working. This isn't willpower failure — it's biology.
Retatrutide's tri-receptor mechanism directly addresses all three hormonal weight drivers simultaneously. GIP activation compensates for estrogen's declining effect on insulin sensitivity. GLP-1 activation restores the hunger signaling that hormonal fluctuations disrupt. Glucagon activation rebuilds the metabolic rate that slows with age.
The result is weight loss that feels different — sustainable, hormonal, and aligned with your body rather than fighting against it.
Addresses hormonal weight resistance
Preserves lean muscle mass
Sustainable fat-focused loss
Restores metabolic rate
Retatrutide is most effective with a gradual titration approach. Always start low and work with a qualified healthcare provider for personalized dosing.
Weeks 1–4
Starting low allows your body to adapt to the compound and minimizes early GI adjustment symptoms. Most women begin noticing reduced appetite within the first 7–10 days.
Weeks 5–8
This is where most women begin seeing consistent, measurable fat loss. Appetite suppression is well-established and metabolic changes become visible in body composition.
Weeks 9–12
Full tri-receptor activation is achieved. Fat oxidation and metabolic rate increases become most pronounced. This phase typically produces the most dramatic visible body composition changes.
Week 13+
Work with your healthcare provider to optimize dose based on results and tolerance. Some women maintain at 2mg; others titrate higher for continued progress or transition to maintenance protocols.
Gather Supplies
Retatrutide vial, bacteriostatic water (BW), 1ml insulin syringe, alcohol wipes, sharps container.
Clean & Wipe
Wipe the top of both the peptide vial and BW vial with an alcohol swab. Allow to dry for 30 seconds.
Draw the Water
Draw the recommended volume of BW (typically 1–2ml) into your syringe slowly.
Add to Vial
Insert needle into the peptide vial and inject BW slowly along the glass wall — never directly onto the powder.
Swirl Gently
Swirl the vial gently in a circular motion until fully dissolved. Never shake. Store reconstituted peptide at 2–8°C.
Dosing information is for educational purposes only. Always consult a licensed healthcare provider before starting any peptide protocol. Individual dosing may vary based on health status, weight, and provider guidance.
You've heard of Ozempic. You may have heard of Mounjaro. Here's exactly how Retatrutide stacks up — and why it consistently outperforms for women.
Feature
Best Choice
Retatrutide
Triple Agonist
Compare
Semaglutide
(Ozempic/Wegovy)
Compare
Tirzepatide
(Mounjaro/Zepbound)
The Bottom Line
Semaglutide (Ozempic) opened the door. Tirzepatide improved on it. Retatrutide is the evolution — the only compound that directly activates fat oxidation through glucagon receptors in addition to GLP-1 and GIP pathways. For women who haven't seen the results they expected from other peptides, or who are dealing with the hormonal weight resistance of perimenopause, Retatrutide represents the most advanced available option.
Ozempic (semaglutide) is a GLP-1 receptor agonist — it activates one metabolic receptor. Retatrutide is a triple agonist that activates three receptors simultaneously: GLP-1 (appetite and satiety), GIP (insulin sensitivity and fat storage), and glucagon (direct fat oxidation and metabolic rate). The glucagon receptor component is what truly distinguishes Retatrutide — no other approved or widely available weight management compound directly activates fat burning at the cellular level the way glucagon agonism does.
Still have questions?
Our women's wellness team is available to help you find the right protocol.
Email Our Team
99.1% HPLC purity. Third-party verified. Formulated for women's hormonal biology. Discreet insulated shipping. Your transformation starts with a single step.
Explore our clinical-grade peptides and add your protocol.